Clinical Trial Update: A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease) [Phase 4]

View source ↗

Summary

Pilot Phase 4 trial investigating mitoxantrone for recurrent neuromyelitis optica (Devic's disease) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Demyelinating Autoimmune Diseases of the Cns
• Neuromyelitis Optica
• Transverse Myelitis

Drugs mentioned

• Mitoxantrone (mitoxantrone)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Neuromyelitis Optica, Myelitis, Transverse | Phase 4 | Status: COMPLETED